These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 22116819)

  • 21. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.
    Ju X; Ijaz T; Sun H; Lejeune W; Vargas G; Shilagard T; Recinos A; Milewicz DM; Brasier AR; Tilton RG
    J Am Heart Assoc; 2014 Jan; 3(1):e000476. PubMed ID: 24449804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome.
    Jespersen K; Li C; Batra R; Stephenson CA; Harding P; Sestak K; Foley RT; Greene H; Meisinger T; Cook JR; Baxter BT; Xiong W
    J Immunol Res; 2022; 2022():7538649. PubMed ID: 35211631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated Marfan syndrome model recapitulates established signaling pathways.
    Gensicke NM; Cavanaugh NB; Andersen ND; Huang T; Qian L; Dyle MC; Turek JW
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1719-1726. PubMed ID: 31272746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome.
    Haskett D; Doyle JJ; Gard C; Chen H; Ball C; Estabrook MA; Encinas AC; Dietz HC; Utzinger U; Vande Geest JP; Azhar M
    Cell Tissue Res; 2012 Jan; 347(1):267-77. PubMed ID: 22105919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating transforming growth factor-beta in Marfan syndrome.
    Matt P; Schoenhoff F; Habashi J; Holm T; Van Erp C; Loch D; Carlson OD; Griswold BF; Fu Q; De Backer J; Loeys B; Huso DL; McDonnell NB; Van Eyk JE; Dietz HC;
    Circulation; 2009 Aug; 120(6):526-32. PubMed ID: 19635970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-TGFβ (Transforming Growth Factor β) Therapy With Betaglycan-Derived P144 Peptide Gene Delivery Prevents the Formation of Aortic Aneurysm in a Mouse Model of Marfan Syndrome.
    Arce C; Rodríguez-Rovira I; De Rycke K; Durán K; Campuzano V; Fabregat I; Jiménez-Altayó F; Berraondo P; Egea G
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):e440-e452. PubMed ID: 34162229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aortic microcalcification is associated with elastin fragmentation in Marfan syndrome.
    Wanga S; Hibender S; Ridwan Y; van Roomen C; Vos M; van der Made I; van Vliet N; Franken R; van Riel LA; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; Essers J; de Waard V
    J Pathol; 2017 Nov; 243(3):294-306. PubMed ID: 28727149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal cystic disease in the Fbn1
    Hibender S; Wanga S; van der Made I; Vos M; Mulder BJ; Balm R; de Vries CJ; de Waard V
    Cardiovasc Pathol; 2019; 38():1-6. PubMed ID: 30359839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgens Accentuate TGF-β Dependent Erk/Smad Activation During Thoracic Aortic Aneurysm Formation in Marfan Syndrome Male Mice.
    Tashima Y; He H; Cui JZ; Pedroza AJ; Nakamura K; Yokoyama N; Iosef C; Burdon G; Koyano T; Yamaguchi A; Fischbein MP
    J Am Heart Assoc; 2020 Oct; 9(20):e015773. PubMed ID: 33059492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
    Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
    J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitro-oleic acid reduces thoracic aortic aneurysm progression in a mouse model of Marfan syndrome.
    Nettersheim FS; Lemties J; Braumann S; Geißen S; Bokredenghel S; Nies R; Hof A; Winkels H; Freeman BA; Klinke A; Rudolph V; Baldus S; Mehrkens D; Mollenhauer M; Adam M
    Cardiovasc Res; 2022 Jul; 118(9):2211-2225. PubMed ID: 34324651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
    Chung AW; Au Yeung K; Cortes SF; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Br J Pharmacol; 2007 Apr; 150(8):1075-83. PubMed ID: 17339838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AAV-mediated AP-1 decoy oligonucleotide expression inhibits aortic elastolysis in a mouse model of Marfan syndrome.
    Remes A; Arif R; Franz M; Jungmann A; Zaradzki M; Puehler T; Heckmann MB; Frey N; Karck M; Kallenbach K; Hecker M; Müller OJ; Wagner AH
    Cardiovasc Res; 2021 Nov; 117(12):2459-2473. PubMed ID: 33471064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome.
    Xiong W; Meisinger T; Knispel R; Worth JM; Baxter BT
    Circ Res; 2012 Jun; 110(12):e92-e101. PubMed ID: 22550139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology and Management of Cardiovascular Manifestations in Marfan and Loeys-Dietz Syndromes.
    Takeda N; Yagi H; Hara H; Fujiwara T; Fujita D; Nawata K; Inuzuka R; Taniguchi Y; Harada M; Toko H; Akazawa H; Komuro I
    Int Heart J; 2016 May; 57(3):271-7. PubMed ID: 27181042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway.
    Gomez D; Al Haj Zen A; Borges LF; Philippe M; Gutierrez PS; Jondeau G; Michel JB; Vranckx R
    J Pathol; 2009 May; 218(1):131-42. PubMed ID: 19224541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome.
    Zilberberg L; Phoon CK; Robertson I; Dabovic B; Ramirez F; Rifkin DB
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):14012-7. PubMed ID: 26494287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.
    Nistala H; Lee-Arteaga S; Carta L; Cook JR; Smaldone S; Siciliano G; Rifkin AN; Dietz HC; Rifkin DB; Ramirez F
    Hum Mol Genet; 2010 Dec; 19(24):4790-8. PubMed ID: 20871099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lineage-Specific Induced Pluripotent Stem Cell-Derived Smooth Muscle Cell Modeling Predicts Integrin Alpha-V Antagonism Reduces Aortic Root Aneurysm Formation in Marfan Syndrome Mice.
    Nakamura K; Dalal AR; Yokoyama N; Pedroza AJ; Kusadokoro S; Mitchel O; Gilles C; Masoudian B; Leipzig M; Casey KM; Hiesinger W; Uchida T; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1134-1153. PubMed ID: 37078287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm.
    Nataatmadja M; West M; West J; Summers K; Walker P; Nagata M; Watanabe T
    Circulation; 2003 Sep; 108 Suppl 1():II329-34. PubMed ID: 12970255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.